"10.1371_journal.pone.0112109","plos one","2014-11-26T00:00:00Z","Christopher J Lelliott; Andrea Ahnmark; Therese Admyre; Ingela Ahlstedt; Lorraine Irving; Feenagh Keyes; Laurel Patterson; Michael B Mumphrey; Mikael Bjursell; Tracy Gorman; Mohammad Bohlooly-Y; Andrew Buchanan; Paula Harrison; Tristan Vaughan; Hans-Rudolf Berthoud; Daniel Lindén","Cardiovascular & Metabolic Disease Innovative Medicines, Dept of Bioscience Diabetes, AstraZeneca, Mölndal, Sweden; Discovery Sciences Transgenics, AstraZeneca, Mölndal, Sweden; Antibody Discovery and Protein Engineering, MedImmune, Cambridge, United Kingdom; Neurobiology of Nutrition Laboratory, Pennington Biomedical Research Center, Baton Rouge, United States of America; AstraZeneca, Discovery Sciences, Mereside, Alderley Park, Macclesfield, Cheshire, United Kingdom","Conceived and designed the experiments: CL AA MB MB-Y AB PH TV H-RB DL. Performed the experiments: CL AA TA IA LI FK LP MM MB TG DL. Analyzed the data: CL AA TA IA LI FK LP MM MB TG PH H-RB DL. Wrote the paper: CL MB MB-Y AB PH TV H-RB DL.","All authors except L.P., M.B.M., and H-R.B. are/were AstraZeneca or MedImmune employees and have stock options in these companies. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","11","Christopher J Lelliott","CJL",16,TRUE,9,11,13,8,TRUE,TRUE,FALSE,0,NA,FALSE
